Korean Stock

FSS DART Disclosures
PERI

COTS Technology

★★★★
 COTS Technology Reports Q1 2026 Revenue of KRW 16.9B, Operating Profit KRW 1.4B... Defense Orders Grow and Dividend Maintained

2026-05-15 16:11

PERI

Seoul Pharma

☆
 Seoul Pharma Q1 2026: Net Loss but Improved Cash Flow and Net Cash Position

2026-05-15 16:11

PERI

SOS LAB

★★
 SOS LAB Q1 2026: Revenue Plunge, Losses Widen, Credit Rating Downgraded

2026-05-15 16:11

PERI

Aligned Genetics

☆
 Aligned Genetics Q1 2026: Consolidated Revenue 3.64B KRW, Operating Profit 0.23B KRW, Down YoY

2026-05-15 16:11

PERI

ICTK

☆
 ICTK Q1 2026: Revenue Grows 46% YoY, Net Loss Narrows

2026-05-15 16:11

PERI

Celemics

★★
 Celemics reports sharp revenue decline and large net loss in Q1 2026, secures liquidity through capital raising

2026-05-15 16:11

PERI

NanoenTek

★
 NanoEntek: 2026 Q1 Consolidated Revenue 10,491 Mln Won, Operating Profit 149 Mln Won

2026-05-15 16:11

PERI

BLUEMTEC

☆
 Bluemtec Q1 2026: Revenue +28.8%, Operating Loss Narrows, Net Profit Turns Positive (Incl. Non-Recurring Gains)

2026-05-15 16:11

PERI

Bohae Brewery

★★
 Bohae Brewery Reports Improved Q1 2026 Results and Expanded Share Buyback

2026-05-15 16:11

PERI

OYANG

★★★
 Sajo Oyang Q1 2026: Operating Profit Surges 85%, Net Income Improves Sharply

2026-05-15 16:11

← PreviousNext →